companies > R > Ranbaxy Ranbaxy European regulator fines Ranbaxy and 8 others for blocking generic drugs 19 June 2013 Apollo Pharma reviewing sale of Ranbaxy drugs, but no ban yet 08 June 2013 Indian doctors’ body asks DCGI to probe Ranbaxy drug quality 29 May 2013 Daiichi admits Ranbaxy hid info from US drug regulators 23 May 2013 Ranbaxy fined $500 mn by US regulator over drug safety lapses 14 May 2013 US FDA disallows Ranbaxy's Indian-manufactured generic Lipitor in US 05 March 2013 Ranbaxy to restart production of generic version of cholesterol-lowering drug Lipitor 25 February 2013 Ranbaxy recalls generic Lipitor in US market over glass particles in bottles 24 November 2012 Ranbaxy to invest $40 million to set up a second plant in Malaysia 13 September 2012 Ranbaxy in licensing pact with Gilead for HIV drug 03 August 2012 Daiichi Sankyo to market Ranbaxy drugs in Venezuela 20 June 2012 Ranbaxy rides a generic sales boom to a Rs1,247-crore Q4 net profit 09 May 2012 Ranbaxy launches India's first new drug for malaria, Synriam 25 April 2012 Ranbaxy begins US exports of generic Lipitor from Mohali 02 April 2012 Ranbaxy opens new manufacturing facility in Morocco 12 March 2012 Ranbaxy launches cholesterol-lowering drug `Atorvastatin’ in Europe 06 March 2012 Ranbaxy may hand over Latin American marketing to Daiichi Sankyo 25 February 2012 Ranbaxy reports Rs2,983 crore Q4 loss on US probe provisioning 23 February 2012 Ranbaxy launches generic version of cholesterol-lowering drug Lipitor in Australia 21 February 2012 Ranbaxy to pay $500 million to settle USFDA ban 21 December 2011 Ranbaxy to share Lipitor profits with Teva 02 December 2011 US FDA lifts curbs on Ranbaxy's generic Lipitor sales 01 December 2011 No immediate gain for Ranbaxy despite Lipitor patent's expiry 30 November 2011 Pfizer, Ranbaxy sued over Lipitor price fixing in the US 10 November 2011 Ranbaxy Labs reports Rs465-crore net loss for July-September quarter 09 November 2011 Ranbaxy to launch generic ‘Lipitor’ in US by November 09 September 2011 Ranbaxy’s subsidiary launches esomeprazole in UK 05 September 2011 Ranbaxy introduces two-in-one painkiller 'Volini Duo' for OTC sales 12 August 2011 Ranbaxy April-June net down over 25 per cent at Rs243 crore 05 August 2011 Ranbaxy in settlement talks with USFDA: Reports 05 May 2011 Mylan Inc sues USFDA to block Ranbaxy’s Lipitor bid 21 March 2011 Ranbaxy, Russian region sign MoU on healthcare cooperation 31 January 2011 Merck and Ranbaxy end drug development pact 06 January 2011 Ranbaxy arm in $134-million AIDS drug supply deal with South African government 20 December 2010 Ranbaxy registers 168 per cent leap in end-Sept profit 12 November 2010 Ranbaxy to gets FDA nod to market generic Aricept in UStember 22 September 2010 Atul Sobti quits as Ranbaxy MD & CEO; Arun Sawhney steps in as MD, leaving CEO slot vacant 12 August 2010 Ranbaxy recalls nerve pain drug from UK market 04 June 2010 Ranbaxy boosts Daiichi Sankyo’s Q1 profits 13 May 2010 Ranbaxy posts spectacular profit from last year's loss 11 May 2010 Ranbaxy recalls two consignments of drugs from US market 15 April 2010 Ranbaxy, Dow arm tie up to develop biosimilar protein 29 March 2010 US FDA rejects Ranbaxy's application for generic Flomax 03 March 2010 Ranbaxy swings back to profit 25 February 2010 US FDA asks Ranbaxy to ensure plant standards compliance: report 05 February 2010 Ranbaxy acquires Biovel to enter vaccines business 19 January 2010 Ranbaxy sells Chinese JV stake to state-owned firm 29 December 2009 Ranbaxy again feels FDA heat – this time over US plant 26 December 2009 Ranbaxy to launch anti-hypertensive drug in six African countries 21 December 2009 Ranbaxy exits JV with Japan’s Nippon Chemiphar 09 December 2009 Ranbaxy launches generic herpes drug in US 27 November 2009 Ranbaxy posts Rs186.08 crore in Q2 profits 27 October 2009 EU official raid Ranbaxy French unit 08 October 2009 Securities Tribunal asks Daiichi to offer Rs160 per Zenotech share 08 October 2009 Ranbaxy to market Daiichi Sankyo products in Mexico 05 October 2009 Ranbaxy in-licenses cosmetic product Neuronox from Medy-Tox, South Korea 17 September 2009 Ranbaxy launches authorised generic version of Validus's Rocaltrol 03 September 2009 Ranbaxy's peptic ulcer drug cleared for US launch 25 August 2009 Religare bids for ING’s Asian assets 17 August 2009 Ranbaxy to market cholesterol-lowering drug in Canada 21 July 2009 Ranbaxy's US subsidiary recalls anti-acne drug from US market 10 July 2009 Daiichi Sankyo to raise $3 billion in bonds to repay Ranbaxy’s acquisition loan 01 June 2009 Ranbaxy holds breath as FDA scrutinises corrective action plan 30 May 2009 Markets cheer Malvinder’s exit from Ranbaxy 26 May 2009 Ranbaxy seeks to downplay Malvinder exit 25 May 2009 Malvinder Singh relinquishes charge of Ranbaxy; Daiichi takes over 25 May 2009 Ranbaxy acquires rights for Ochoa Labs’ skincare products 22 May 2009 Religare in race for AIG's fund management unit 12 May 2009 Ranbaxy's anti-malaria molecule enters Phase III clinical trial 06 May 2009 Ranbaxy recalls Nitrofurantoin capsules in the US 02 May 2009 Fortis investing Rs2,500 crore to expand network, double capacity 08 April 2009 Aurobindo's HIV drug, Ranbaxy's epillepsy drug get USFDA nod 01 April 2009 Ranbaxy to launch Daiichi's hypertension drug in India 31 March 2009 After Matrix who will be delisted next? 28 March 2009 Ranbaxy investment arm Religare hikes rights issue target 26 March 2009 UK, Australia okay drugs from Ranbaxy plant 24 March 2009 Ranbaxy's cardio drug `Ramipril' gets US FDA approval 09 March 2009 Ranbaxy hospital group Fortis taps outdoor opportunities 03 March 2009 Daiichi, Ranbaxy form team to face FDA charges 27 February 2009 Ranbaxy plant in India falsified data: US FDA 25 February 2009 Bhavdeep Singh becomes CEO of Fortis 24 February 2009 FDA woes hit Ranbaxy in Q4 23 January 2009 Ranbaxy affiliate Zenotech objects to open offer pricing 19 January 2009 Daiichi Sankyo announces valuation loss for Ranbaxy acquisition of 359 billion yen 05 January 2009 Fortis Healthcare plans rights issue to raise Rs2,000 crore for acquisitions 24 December 2008 Malvinder gets additional charge of chairman in reconstituted Ranbaxy board 20 December 2008 Ranbaxy in pact to market BioPro's brain tumour drug in India 03 December 2008 Daiichi Sankyo completes Ranbaxy acquisition 07 November 2008 Ranbaxy investment arm Religare to acquire majority stake in Lotus India AMC 04 November 2008 Daiichi acquires 52.5 per cent in Ranbaxy 20 October 2008 Ranbaxy-Daiichi deal hits a regulatory bump 17 October 2008 Ranbaxy-GSK submits IND application for respiratory inflammation candidate 13 October 2008 Delayed approval of Ranbaxy deal brings $445 million windfall for Daiichi 04 October 2008 Ranbaxy hires New York ex-mayor Giuliani to resolve issues with US FDA 18 September 2008 US FDA bans import of over 30 Ranbaxy generic drugs 17 September 2008 Cabinet likely to clear Daiichi-Ranbaxy deal next month 26 August 2008 Finance ministry clears Daiichi-Ranbaxy deal among 24 FDI proposals 06 August 2008 Daiichi to launch open offer for Ranbaxy on 16 August 05 August 2008 Daiichi awaits SEBI nod for launching open offer for Ranbaxy 02 August 2008 Ranbaxy applies for US FDA approval for Mohali plant; says WHO approves new ARV drug 02 August 2008 Ranbaxy banks on Pfizer settlement to revive falling fortunes 29 July 2008 After amlodipine in Japan, Ranbaxy launches omerprazole 28 July 2008 US House representatives probe FDA approval of Ranbaxy drugs 23 July 2008 UK Crown court rejects charges against Ranbaxy 23 July 2008 MNC rival trying to scuttle Daiichi deal: Ranbaxy 18 July 2008 FDA under probe as Ranbaxy says Daiichi deal is sealed 17 July 2008 Ranbaxy denies allegation of substandard drug sale; gets nod for stake sale 15 July 2008 Reports of coming under US FDA scanner hammer Ranbaxy stock 14 July 2008 AEGON Religare Life Insurance gets IRDA approval 30 June 2008 Tentative nod from USFDA for Ranbaxy's cancer drug valganciclovir 26 June 2008 LIC may offload Ranbaxy stake as it rejigs investment portfolio 19 June 2008 CNBC-TV18 shares with domain-b its exclusive interview with Malvinder Singh 18 June 2008 Pfizer and Ranbaxy settle global Lipitor patent litigation 18 June 2008 Daiichi to make open offer for Ranbaxy on August 8 16 June 2008 Report on Pfizer move buoys Ranbaxy stock to a 3-year high 13 June 2008 Behind the Ranbaxy sale 12 June 2008 This is the start of a much larger game 11 June 2008 Ranbaxy struck deal at appropriate time: PwC 11 June 2008 Japan's Daiichi Sankyo to acquire majority stake in Ranbaxy 11 June 2008 Ranbaxy gets partial relief in `atorvastatin' case in Australia 28 May 2008 Ranbaxy's Religare completes 97-per cent acquisition of UK broking firm Hichens for £56 million 27 May 2008 Ranbaxy's Malvinder Singh among pharma's most influential Indians 19 May 2008 Ranbaxy to develop new drugs for Merck & Co 10 May 2008 Ranbaxy gets a boost as US patent office rejects Pfizer's Liptor plea 28 April 2008 Ranbaxy forces Orchid into an alliance 22 April 2008 Ranbaxy settles litigation with AstraZeneca; to sell Nexium in US 15 April 2008 Why Ranbaxy fancies Orchid 14 April 2008 Ranbaxy group closer to 15 per cent stake in Orchid 14 April 2008 Ranbaxy's Solrex picks up 1 per cent more in Orchid Chemicals 11 April 2008 Orchid Chemicals stock surges as Ranbaxy group hikes stake 08 April 2008 Ranbaxy receives Japanese authorisation for product development outside Japan 08 April 2008 Ranbaxy introduces world's first biogeneric injectible drug for osteoporosis 03 April 2008 Ranbaxy's Religare becomes first Indian brokerage to acquire London firm 26 March 2008 Ranbaxy to introduce dental drug Inersan in India, Nepal 18 March 2008 SC refuses to stay Gujarat HC order on Ranbaxy's 'Volini' ad 12 March 2008 Ranbaxy board approves de-merger of new drug discovery research unit in to Ranbaxy Life Science Research Ltd 19 February 2008 USFDA grants tentative approval to Ranbaxy's esomeprazole magnesium DR capsules in the US 07 February 2008 US FDA approves Ranbaxy's generic version of GlaxoSmithKline's Ceftin for US sales 06 February 2008 Ranbaxy announces settlement of possible Imitrex litigation with Glaxosmithkline 21 January 2008 Ranbaxy enters Chyawanprash market with suger-free `Chyawan Active' 11 January 2008 Ranbaxy wins patent case against Pfizer cholestrol drug Liptor in Germany 30 October 2007 Ranbaxy launches Osonase nasal spray in India 25 October 2007 Ranbaxy follows Sun Pharma in demerging R&D business 19 October 2007 Ranbaxy plans to spin off research arm as Q3 net profit zooms 48 per cent 18 October 2007 Ranbaxy to raise stake in Zenotech Laboratories 13 October 2007 Zenotech to boost Ranbaxy''s presence in generic biopharmaceuticals 09 October 2007 Ranbaxy to up Zenotech Lab stake to 45 per cent for Rs214 crore 03 October 2007 Ranbaxy enters in-licensing agreement with Sirtex Medical to market SIR-Spheres for liver cancer 24 September 2007 Ranbaxy receives WHO pre-qualification for three more ARVS 15 September 2007 Ranbaxy launches urology drug Roliflo OD based on multiparticulate technology 14 September 2007 Ranbaxy wins Lipitor case in Canadian Federal Court; Pfizer''s application on atorvastatin dismissed 13 September 2007 Ipca-Ranbaxy alliance to market Metformin HCL tablets in US 14 August 2007 Ranbaxy to sell authorised generics product Isoptin SR in US 30 July 2007 Significant opportunities for Ranbaxy from GlaxoSmithKline deal: Malvinder Singh 26 July 2007 Ranbaxy, GSK to settle valacyclovir patent case in US 26 July 2007 Ranbaxy to benefit from 180-day US market exclusivity for its pravastatin 25 June 2007 Ranbaxy buys 13 dermatology brands from Bristol-Myers 28 May 2007 US FDA approves Ranbaxy''s pravastatin sodium tablets 25 April 2007 Ranbaxy Labs acquires 14.9-per cent stake in Jupiter Bio Science 07 April 2007 Terapia Ranbaxy receives 3-year GMP certification renewal for Bucharest facility 04 April 2007 Ranbaxy-GSK alliance to develop respiratory drug 02 April 2007 Ranbaxy launches asthma drug 'Osovair' in India 30 March 2007 Ranbaxy withdraws bid for Merck's generic business 20 March 2007 Ranbaxy enters second round of bidding for Merck unit: report 16 March 2007 Ranbaxy gets USFDA nod for zolpidem tablet production in US 16 March 2007 Ranbaxy Laboratories Bids for Merck''s Generic Unit 13 March 2007 US firm acquires global rights for anti-cholestrol drug from Ranbaxy 01 March 2007 Ranbaxy plans ADS offering to finance Merck arm acquisition 21 February 2007 Ranbaxy enters biosimilar product space with Zenotech, targets EU markets 08 February 2007 Ranbaxy-Glaxo extend pact 07 February 2007 Glaxo moves court against Ranbaxy''s generic drug 03 February 2007 Ranbaxy launches two NDDS Urology products in India 30 January 2007 Ranbaxy pitted against Texas Pacific, Cinven, Permira for Merck''s generic-drug unit 12 January 2007 Ranbaxy to bid over $5 billion for Merck Generics 09 January 2007 Ipca - Ranbaxy alliance receive US FDA marketing approval for atenolol tablets 02 January 2007 Ranbaxy wins Lipitor patent against Pfizer in Australia 21 December 2006 Ranbaxy, department of science and technology to jointly develop new drugs 18 December 2006 Ranbaxy gets USFDA approval for Cefprozil anti-infective tablets 15 December 2006 Ranbaxy acquires South Africa's fifth largest generics company 01 December 2006 US Court''s Zocor verdict to benefit Ranbaxy and Dr Reddy''s 15 November 2006 Ranbaxy to introduce Debiopharm's gastro drug in India 23 October 2006 US FDA approves Ranbaxy's sale of furosemide in the US 21 September 2006 Ranbaxy to market Ethypharm's cardiovascular drug in India 18 September 2006 Fortis emerges a winner in Delhi''s pvt healthcare sector 13 September 2006 Ranbaxy receives US FDA nod to market loperamide hydrochloride and simethicone tablets 11 September 2006 Ranbaxy wins two additional atorvastatin patents in Norway 30 August 2006 Ranbaxy receives tentative US FDA approval to market Risperidone oral solution 05 August 2006 Mixed victory for Ranbaxy in patent row with Pfizer 03 August 2006 Ranbaxy Q2 global sales up 7 per cent at $317 million; net vaults 20 per cent 20 July 2006 Ranbaxy acquires GlaxoSmithKline subsidiary Mundogen in Spain 18 July 2006 Ranbaxy's 'Cefprozil' gets US FDA approval 01 July 2006 U K appeals court affirms HC ruling in Ranbaxy-Pfizer case 28 June 2006 Ranbaxy gains WHO pre-qualification for four more ARVs 24 May 2006 Ranbaxy reports steady Q1 numbers; helped by strong domestic sales 20 April 2006 CRISIL reaffirms rating of RANBAXY LABORATORIES following acquisition announcement 04 April 2006 Triple strike : Ranbaxy in third European acquisition in three days 31 March 2006 Ranbaxy acquires Romanian drug firm for $324 million 29 March 2006 Ranbaxy to acquire Glaxo's generic business in Italy 28 March 2006 Ranbaxy acquires patent & rights for auto-injector device 21 March 2006 Ranbaxy Laboratories ties-up with Zenotech to market cancer injectibles 09 March 2006 Setback for Ranbaxy; Finnish court reverses earlier verdict on Lipitor 22 February 2006 Dr Reddy's beats Ranbaxy; snaps up Betapharm for €480 million 16 February 2006 Ranbaxy raises $400 million from FCCB issue 16 February 2006 Ranbaxy forms South African JV to sell AIDS drug 06 February 2006 Dr Reddy's, Ranbaxy lead race to acquire 3i's stake in Betapharm 03 February 2006 Ranbaxy in co-marketing agreement with Ferring of Switzerland 10 January 2006 Ranbaxy, Cephalon to settle Provigil patent litigation 22 December 2005 Ranbaxy to appeal US District Court decision upholding Pfizer Atorvastatin Patents 19 December 2005 Ranbaxy offers to help U S combat avian flu 02 December 2005 Ranbaxy honours scientists for outstanding research 28 November 2005 US Court of Appeals upholds preliminary injunction against Ranbaxy 23 November 2005 AstraZeneca sues Ranbaxy on Nexium patent 22 November 2005 Ranbaxy scores over Pfizer in Norwegian court over cholesterol drug 10 November 2005 CRISIL reaffirms Ranbaxy''s outstanding ratings despite court ruling 15 October 2005 Ranbaxy obtains US FDA approval for high BP drug 14 September 2005 Ranbaxy, JB Chem to market Doktor Mom brand in Romania 06 July 2005 Maharashtra FDA questions claims of nutraceuticals 28 June 2005 USFDA gives tentative nod for Ranbaxy drug 01 June 2005 The rest didn''t do badly, either 16 February 2005 Ranbaxy makes three fresh ARV filings to WHO 25 January 2005 Ranbaxy Top brass reshuffled 22 January 2005 Ranbaxy Q4 results disappoints 19 January 2005 Ranbaxy withdraws its antiretroviral''s from WHO list 10 November 2004 Fortis to invest over Rs1,100 crore in integrated healthcare delivery system 17 August 2004 Ranbaxy net down six per cent 02 August 2004 Ranbaxy in pact for new drug discovery 30 April 2004 Ranbaxy crosses the billion dollar mark 11 March 2004 Ranbaxy enters the field of herbal medicine 22 January 2004 USFDA approval for Ranbaxy drug 10 January 2004 Retreat of a titan 29 December 2003 Ranbaxy''s first round of talks to acquire RPG Life Sciences over 05 December 2003 WHO declares pre-qualification of Ranbaxy''s Triviro-LNS tablets 04 December 2003 Ranbaxy to invest Rs 120 crore for R&D in Andhra Pradesh 22 September 2003 FIIs, banks up holdings in Ranbaxy, Dr Reddy''s, Nicholas Piramal, Cipla 21 July 2003 Ranbaxy, MMV Geneva in R&D tie-up for anti-malarial drug 19 May 2003 Ranbaxy to provide AIDS drugs to 10 lakh patients 29 November 2002 Ranbaxy Laboratories clocks Rs 1,594-million Q2 net profit 18 October 2002 Ranbaxy secures 10% stake in Nihon Pharma 26 September 2002 Ranbaxy gets USFDA approval for Terazosin 26 September 2002 Ranbaxy refutes Glaxo’s charge of stealing 24 August 2002 Glaxo SmithKline to sue Novartis, Ranbaxy 23 August 2002 Ranbaxy acquires Signature Pharma facility 23 July 2002 Ranbaxys new chemical entity gets license 27 June 2002 Ranbaxy Labs wants to buy out SRL 14 February 2002 Ranbaxy joins hands with NIPER 10 January 2002 Pharma sector fared well in 2001 28 December 2001 Sildenafil citrate drug sales surge 05 December 2001 The future is bright for pharma firms 21 November 2001 Ranbaxy Fine Chemicals Ltd 01 March 2000 Ranbaxy to sell ranitidine 75mg tablets in the US 13 January 2000 Ranbaxy closes $65 million Bayer deal 09 September 1999 Ranbaxy to raise research spending to 6 per cent of sales by 2002 09 September 1999 Ode to a visionary 04 July 1999 Hoechst, Nicholas Piramal to co-market two products 01 July 1999 Ranbaxy in talks with Bayer for licensing ciprofloxacin delivery system 25 June 1999 Ranbaxy pushes Pravosin to phase-1 trials 30 May 1999 Ajanta, Ranbaxy plan co-marketing 27 April 1999  search domain-b    go
Legal Policy | Copyright © 1999-2013 The Information Company Private Limited. All rights reserved.